Religare Securities

Nifty Today, Stocks to Buy Today: The Nifty has breached a critical support level at 24,300, and the sharp decline in the banking sector is exacerbating the weakness

Pharma index has rebounded from the key support zone and LUPIN is offering fresh buying opportunity with favorable risk to reward

In a stock exchange filing, Religare said both resolutions have 'failed to pass with requisite majority as per Section 114(2) of the Act'

Airtel's stock has surpassed the hurdle around 540 levels

TITAN, after the breakout from a consolidation range, is gradually inching higher while holding strongly above the support zone of the long term moving average( 200 EMA) on the daily chart

Balkrishna Industries is currently hovering in a range while holding strong above the support zone of 20 EMA on the daily charts

The up-move in Asian Paints was supported by an exceptional rise in volume, indicating a possible continuation of the positive momentum

CONCOR has retraced considerably from its record high and reached closer to the support zone of the long-term moving average (200 EMA) on the daily chart

Currently, Ramo Cements' stock is hovering in a range, after a sharp up move, offering fresh buying opportunity to those who missed the chance earlier

On January 14, Berger Paint's stock surged strongly and made a new record high, supported with a noticeable rise in volume

UltraTech Cement has recently surpassed the hurdle of multiple moving averages on the daily chart and is likely to witness fresh momentum

Ashok Leyland has been rebounding for the past five months and is now trading on the verge of fresh breakout from the consolidation range

In the banking space, private banking majors are leading from the front and still looking buoyant

While the other IT counters are witnessing volatile swings or reeling under pressure, Tech Mahindra is comfortably holding above the support zone of multiple moving averages on the daily chart

Here are the weekly stock recommendations by Religare Broking

Here are the weekly stock recommendations by Religare Broking

A spokesman declined to give more details, and said company continued to asses the situation